{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:47:52Z","timestamp":1792043272140,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020604","name":"Novartis Portugal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"DOI":"10.1007\/s13555-026-01955-z","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:15:51Z","timestamp":1792041351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-9956","authenticated-orcid":false,"given":"Pedro S.","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-3803","authenticated-orcid":false,"given":"Jorge M.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-2679","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Maia Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"1955_CR1","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1111\/all.70210","volume":"81","author":"T Zuberbier","year":"2026","unstructured":"Zuberbier T, Ansari ZAH, Abdul Latiff AH, et al. The international guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2026;81:2582\u2013632.","journal-title":"Allergy"},{"key":"1955_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","volume":"8","author":"P Kolkhir","year":"2022","unstructured":"Kolkhir P, Gim\u00e9nez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers. 2022;8:61.","journal-title":"Nat Rev Dis Primers"},{"key":"1955_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/all.14037","volume":"75","author":"J Fricke","year":"2020","unstructured":"Fricke J, \u00c1vila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75:423\u201332.","journal-title":"Allergy"},{"key":"1955_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2230.2010.03840.x","volume":"35","author":"T Zuberbier","year":"2010","unstructured":"Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35:869\u201373.","journal-title":"Clin Exp Dermatol"},{"key":"1955_CR5","first-page":"315","volume":"74","author":"C Costa","year":"2016","unstructured":"Costa C, Campina S, Andrade P, Filipe P, Guilherme A, Gon\u00e7alo M. Urtic\u00e1ria cr\u00f3nica\u2014do diagn\u00f3stico ao tratamento. J Port Soc Dermatol Venereol. 2016;74:315\u201325.","journal-title":"J Port Soc Dermatol Venereol"},{"key":"1955_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ad.2019.03.005","volume":"110","author":"D Carvalho","year":"2019","unstructured":"Carvalho D, Aguiar P, Ferrinho P, Mendes-Bastos P, Palma-Carlos A. Eczema and urticaria in the adult population in Portugal: a prevalence study. Actas Dermosifiliogr. 2019;110:744\u201351.","journal-title":"Actas Dermosifiliogr"},{"key":"1955_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/bjd.19561","volume":"184","author":"M Gon\u00e7alo","year":"2021","unstructured":"Gon\u00e7alo M, Gim\u00e9nez-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184:226\u201336.","journal-title":"Br J Dermatol"},{"key":"1955_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-70385-w","author":"PS Coelho","year":"2026","unstructured":"Coelho PS, Mendes JM, Maia e Silva J. The burden of chronic urticaria in Portuguese patients: a patient-reported observational study. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-70385-w.","journal-title":"Sci Rep"},{"key":"1955_CR9","doi-asserted-by":"publisher","first-page":"adv36122","DOI":"10.2340\/actadv.v104.36122","volume":"104","author":"A Baudy","year":"2024","unstructured":"Baudy A, Raison-Peyron N, Serrand C, Cr\u00e9py MN, Du-Thanh A. Impact of chronic spontaneous or inducible urticaria on occupational activity. Acta Derm Venereol. 2024;104:adv36122.","journal-title":"Acta Derm Venereol"},{"key":"1955_CR10","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.waojou.2020.100460","volume":"13","author":"M Maurer","year":"2020","unstructured":"Maurer M, Gim\u00e9nez-Arnau A, Ensina LF, Chu CY, Jaumont X, Tassinari P. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organ J. 2020;13:100460.","journal-title":"World Allergy Organ J"},{"key":"1955_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/ced.14230","volume":"45","author":"S Savic","year":"2020","unstructured":"Savic S, Leeman L, El-Shanawany T, et al. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study. Clin Exp Dermatol. 2020;45:1003\u201310.","journal-title":"Clin Exp Dermatol"},{"key":"1955_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.20344\/amp.9496","volume":"32","author":"AC Costa","year":"2019","unstructured":"Costa AC, Rosmaninho I, Guilherme A, et al. Chronic urticaria in the real-life clinical practice setting in Portugal: baseline results from the non-interventional multicentre AWARE study. Acta Med Port. 2019;32:133\u201340.","journal-title":"Acta Med Port"},{"key":"1955_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20344\/amp.14477","volume":"35","author":"C Costa","year":"2022","unstructured":"Costa C, Rosmaninho I, AWARE Portuguese Study Investigational Group. Chronic urticaria in the real-life clinical practice setting in Portugal: two-year results from the non-interventional multicenter AWARE study. Acta Med Port. 2022;35:12\u20139.","journal-title":"Acta Med Port"},{"key":"1955_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/cea.13716","volume":"50","author":"M Maurer","year":"2020","unstructured":"Maurer M, Costa C, Gim\u00e9nez-Arnau A, et al. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin Exp Allergy. 2020;50:1166\u201375.","journal-title":"Clin Exp Allergy"},{"key":"1955_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14656566.2024.2345731","volume":"25","author":"YK Xiang","year":"2024","unstructured":"Xiang YK, Fok JS, Podder I, et al. An update on the use of antihistamines in managing chronic urticaria. Expert Opin Pharmacother. 2024;25:551\u201369.","journal-title":"Expert Opin Pharmacother"},{"key":"1955_CR16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s13555-023-00972-6","volume":"13","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Biazus Soares G, Mahmoud O. Current and emerging therapies for chronic spontaneous urticaria: a narrative review. Dermatol Ther. 2023;13:1647\u201360.","journal-title":"Dermatol Ther"},{"key":"1955_CR17","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s13555-023-01040-9","volume":"13","author":"TB Casale","year":"2023","unstructured":"Casale TB, Gimenez-Arnau AM, Bernstein JA, Holden M, Zuberbier T, Maurer M. Omalizumab for patients with chronic spontaneous urticaria: a narrative review of current status. Dermatol Ther (Heidelb). 2023;13:2573\u201388.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1955_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/all.15030","volume":"77","author":"I Agache","year":"2022","unstructured":"Agache I, Akdis CA, Akdis M, et al. EAACI biologicals guidelines: omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12\u201317 years old. Allergy. 2022;77:17\u201338.","journal-title":"Allergy"},{"key":"1955_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/hpm.3084","volume":"36","author":"MA Pereira","year":"2021","unstructured":"Pereira MA, Marques RC, Ferreira DC. A critical look at the Portuguese public-private partnerships in healthcare. Int J Health Plann Manag. 2021;36:302\u201315.","journal-title":"Int J Health Plann Manag"},{"key":"1955_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12913-020-05620-9","volume":"20","author":"J Sarmento","year":"2020","unstructured":"Sarmento J, Rocha JVM, Santana R. Defining ambulatory care sensitive conditions for adults in Portugal. BMC Health Serv Res. 2020;20:554.","journal-title":"BMC Health Serv Res"},{"key":"1955_CR21","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1038\/s41598-025-91896-y","volume":"15","author":"AS Cunha","year":"2025","unstructured":"Cunha AS, Vitorino G, Maia e Silva J, Coelho PS. Economic burden of atopic dermatitis in Portugal: a cross-sectional study. Sci Rep. 2025;15:7717.","journal-title":"Sci Rep"},{"key":"1955_CR22","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1038\/s41598-024-55965-y","volume":"14","author":"PS Coelho","year":"2024","unstructured":"Coelho PS, Apalh\u00e3o M, Victorino G, Cardoso C, Camilo J, Maia Silva J. The burden of atopic dermatitis in Portuguese patients: an observational study. Sci Rep. 2024;14:5181.","journal-title":"Sci Rep"},{"issue":"Suppl","key":"1955_CR23","first-page":"56","volume":"23","author":"J Carrasco","year":"2015","unstructured":"Carrasco J, Costa C, Gon\u00e7alo M, Guilherme M, Rodrigues Martins A. Qual \u00e9 o impacto econ\u00f3mico da urtic\u00e1ria cr\u00f3nica espont\u00e2nea grave em Portugal? A perspetiva do Servi\u00e7o Nacional de Sa\u00fade e da sociedade portuguesa. Rev Port Imunoalergologia. 2015;23(Suppl):56 (abstract PO29).","journal-title":"Rev Port Imunoalergologia"},{"key":"1955_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaip.2017.10.001","volume":"6","author":"T Hawro","year":"2018","unstructured":"Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria Activity Score: validity, reliability, and responsiveness. J Allergy Clin Immunol Pract. 2018;6:1185\u201390.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1955_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"1955_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1590\/S0365-05962004000500002","volume":"79","author":"GA Martins","year":"2004","unstructured":"Martins GA, Arruda L, Mugnaini ASB. Valida\u00e7\u00e3o de question\u00e1rios de avalia\u00e7\u00e3o da qualidade de vida em pacientes de psor\u00edase. An Bras Dermatol. 2004;79:521\u201335.","journal-title":"An Bras Dermatol"},{"key":"1955_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12955-019-1266-y","volume":"17","author":"PL Ferreira","year":"2019","unstructured":"Ferreira PL, Gon\u00e7alo M, Ferreira JA, et al. Psychometric properties of the Portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL). Health Qual Life Outcomes. 2019;17:190.","journal-title":"Health Qual Life Outcomes"},{"key":"1955_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327\u201337.","journal-title":"Clin Mol Hepatol"},{"key":"1955_CR29","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1136\/ard.2009.117150","volume":"69","author":"WB van den Hout","year":"2010","unstructured":"van den Hout WB. The value of productivity: human-capital versus friction-cost method. Ann Rheum Dis. 2010;69:i89\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1955_CR30","doi-asserted-by":"publisher","first-page":"101081","DOI":"10.1016\/j.waojou.2025.101081","volume":"18","author":"W Soong","year":"2025","unstructured":"Soong W, Patil D, Rodrigues J, et al. Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States. World Allergy Organ J. 2025;18:101081.","journal-title":"World Allergy Organ J"},{"key":"1955_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","volume":"230","author":"MKA Basra","year":"2015","unstructured":"Basra MKA, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230:27\u201333.","journal-title":"Dermatology"},{"key":"1955_CR32","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/all.13209","volume":"72","author":"M Maurer","year":"2017","unstructured":"Maurer M, Abuzakouk M, B\u00e9rard F, et al. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017;72:2005\u201316.","journal-title":"Allergy"},{"key":"1955_CR33","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/jdv.20071","volume":"38","author":"M Augustin","year":"2024","unstructured":"Augustin M, Beier D, Branner J, et al. The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany. J Eur Acad Dermatol Venereol. 2024;38:2102\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1955_CR34","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s13555-026-01669-2","volume":"16","author":"E Vilarrasa","year":"2026","unstructured":"Vilarrasa E, Borr\u00e1s-Blasco J, Lobo-Benito S, et al. Economic burden of hidradenitis suppurativa in Spain. Dermatol Ther. 2026;16:1739\u201356.","journal-title":"Dermatol Ther"},{"key":"1955_CR35","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/jdv.17203","volume":"35","author":"N Mohr","year":"2021","unstructured":"Mohr N, Naatz M, Zeervi L, et al. Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care. J Eur Acad Dermatol Venereol. 2021;35:1346\u201356.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1955_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12913-023-09840-7","volume":"23","author":"Z Beretzky","year":"2023","unstructured":"Beretzky Z, Koszor\u00fa K, Rencz F, et al. Societal costs and health related quality of life in adult atopic dermatitis. BMC Health Serv Res. 2023;23:859.","journal-title":"BMC Health Serv Res"},{"key":"1955_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/14737167.2021.1895753","volume":"22","author":"K G\u00e1sp\u00e1r","year":"2022","unstructured":"G\u00e1sp\u00e1r K, Hunor Gergely L, Jenei B, et al. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study. Expert Rev Pharmacoecon Outcomes Res. 2022;22:399\u2013408.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1955_CR38","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/ijd.17366","volume":"63","author":"PV Chernyshov","year":"2024","unstructured":"Chernyshov PV, Tomas-Aragones L, Zuberbier T, et al. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement. Int J Dermatol. 2024;63:1657\u201367.","journal-title":"Int J Dermatol"},{"key":"1955_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/jdv.16947","volume":"35","author":"K Weller","year":"2021","unstructured":"Weller K, Gim\u00e9nez-Arnau A, Grattan C, et al. The Chronic Urticaria Registry: rationale, methods and initial implementation. J Eur Acad Dermatol Venereol. 2021;35:721\u20139.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01955-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:15:52Z","timestamp":1792041352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":39,"alternative-id":["1955"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01955-z","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"2 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Pedro S. Coelho, Jorge M. Mendes and Jo\u00e3o Maia Silva declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments, and with applicable national regulations for research involving human participants. All participants provided informed consent before participation. The protocol was approved by the ethics committee of NOVA Information Management School (NOVA IMS), Universidade Nova de Lisboa (approval reference OTHER2020-10-287745, 30 October 2020). Data were collected anonymously and processed in accordance with the General Data Protection Regulation (GDPR) and Portuguese data-protection law. No identifying information is included in this article.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}